Schenkein David P Insider Trades

Insider Trading History

Track insider trading activity for Schenkein David P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prime Medicine
Prime Medicine PRME
Director
Holding Value $262k 75,000 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 75,000 shares
$3.06
$3.49
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $499k 21,665 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$504k 25,634 shares
$19.66
$23.02
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.3M 1,962 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.52M 2,117 shares
$716.18
$664.45
Prime Medicine
Prime Medicine PRME
Director
Holding Value $0 0 shares
Last Trade
Aug 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$340k 84,062 shares
$4.04
$3.49
Prime Medicine
Prime Medicine PRME
Director
Holding Value $157k 45,000 shares
Last Trade
Aug 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 84,062 shares
$4.04
$3.49
Prime Medicine
Prime Medicine PRME
Director
Holding Value $192k 55,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$3.49
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $417k 18,111 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 24,148 shares
$13.93
$23.02
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.3M 1,958 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 1,958 shares
$719.37
$664.45
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $0 0 shares
Last Trade
Nov 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.49M 47,165 shares
$31.58
$23.02
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $956k 41,532 shares
Last Trade
Nov 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.93M 59,441 shares
$32.51
$23.02
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $1.58M 68,661 shares
Last Trade
Nov 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.49M 47,165 shares
$31.58
$23.02
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $469k 11,774 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 11,774 shares
$42.45
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $5.03M 126,242 shares
Last Trade
Jun 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$39.87
Prime Medicine
Prime Medicine PRME
Director
Holding Value $157k 45,000 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 45,000 shares
$7.68
$3.49
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $495k 21,496 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 17,901 shares
$18.56
$23.02
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $7.19M 180,325 shares
Last Trade
Feb 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.19M 69,329 shares
$31.64
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $4.9M 122,854 shares
Last Trade
Feb 27, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.4M 69,329 shares
$34.67
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $2.29M 57,471 shares
Last Trade
Feb 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.19M 69,329 shares
$31.64
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $4.9M 122,854 shares
Last Trade
Feb 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$677k 20,411 shares
$33.19
$39.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up